Release Date: 17/04/18 08:25 Summary: Presentation - EGF 2018 Price Sensitive: No Download Document 3.3MB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%